Basic Information
Haichang Biotech, established in October 2013, is a high-tech enterprise founded by an overseas Ph.D. team and dedicated to the research and development of innovative formulations. The company is located in Hangzhou Future Sci-Tech City's Hi-Tech Incubation Park (HaiChuang Park), one of the four national future technology cities and a key innovation base developed during Zhejiang Province’s 12th Five-Year Plan period. Situated in Hangzhou’s western scientific innovation cluster, it neighbors companies like Alibaba and institutions like Zhejiang University, enjoying superior geographical advantages, beautiful surroundings, abundant resources, a concentration of talent, and vast growth potential.The company holds seven authorized invention patents, including "Liposome Carrier for Tumor Drug Delivery and Its Preparation Method and Application" and "Novel Gene Carrier Constructed with Polymer and Its Preparation Method," as well as licensed transfer patents for innovative drug Rx-0301 nucleic acid products and improved new drug Bortezomib Liposome. Haichang Biotech has a core team with extensive experience in liposomal drug research, process amplification, pharmaceutical production, GMP workshop management, and regulatory submission. It also has three major drug development platforms based on gene delivery technology, liposome technology, and microsphere technology. The company focuses on developing technical products such as gene delivery systems, targeted anti-tumor drugs, liposomal nanomedicine formulations, and advanced controlled-release drug delivery systems.Adhering closely to its core values of "Sharing, Progression, Truth-seeking, and Practicality," the company aims to break through the traditional bloody competition of red oceans and target brand-new non-competitive market spaces to achieve faster growth and higher profits. With a long-term vision while focusing on current opportunities, we are committed to becoming an international company integrating R&D, production, and sales in the niche field of innovative formulations, specializing in gene delivery, liposomes, nanomedicine formulations, and microsphere products.
Haichang Biotech
Zhejiang,China
51~100 people
October 25, 2013
wangcc@zhejianghaichang.com

